Patents by Inventor Matthew Frankel

Matthew Frankel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230313323
    Abstract: The present disclosure relates to materials and methods for amplifying and detecting 2019-CoV in a sample, comprising a variety of combinations of amplification oligonucleotides and oligonucleotide probes. The disclosure also relates to oligonucleotide sequences, kits, and methods for detecting COVID-19.
    Type: Application
    Filed: March 26, 2021
    Publication date: October 5, 2023
    Inventors: Richard Roth, Jessica Koranda, Andrew Morris, Mario Neto, Ka-Cheung Luk, Matthew Frankel, Klara Abravaya, Dan Toolsie, Gavin Cloherty
  • Publication number: 20200115767
    Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
    Type: Application
    Filed: October 25, 2019
    Publication date: April 16, 2020
    Inventors: Charles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John R. Hackett, JR., Matthew Frankel, Kenn Forberg
  • Patent number: 10501816
    Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: December 10, 2019
    Assignees: ABBOTT LABORATORIES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Charles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John R. Hackett, Jr., Matthew Frankel, Kenn Forberg
  • Patent number: 10378069
    Abstract: The invention is directed to compositions, kits, and methods for amplifying and detecting a Zika virus nucleic acid sequence in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: August 13, 2019
    Assignee: Abbott Molecular Inc.
    Inventors: Matthew Frankel, George Schneider
  • Publication number: 20180230555
    Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
    Type: Application
    Filed: February 9, 2018
    Publication date: August 16, 2018
    Inventors: Charles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John R. Hackett, JR., Matthew Frankel, Kenn Forberg
  • Patent number: 9938589
    Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: April 10, 2018
    Assignees: Abbott Laboratories, The Regents of the University of California
    Inventors: Charles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John R. Hackett, Jr., Matthew Frankel, Kenn Forberg
  • Publication number: 20170369931
    Abstract: The invention is directed to compositions, kits, and methods for amplifying and detecting a Zika virus nucleic acid sequence in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
    Type: Application
    Filed: June 26, 2017
    Publication date: December 28, 2017
    Inventors: Matthew Frankel, George Schneider
  • Publication number: 20170306426
    Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
    Type: Application
    Filed: July 6, 2017
    Publication date: October 26, 2017
    Inventors: Charles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John R. Hackett, JR., Matthew Frankel, Kenn Forberg
  • Patent number: 9777340
    Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: October 3, 2017
    Assignees: Abbott Laboratories, The Regents of the University of California
    Inventors: Charles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John Hackett, Matthew Frankel, Kenn Forberg
  • Publication number: 20150376722
    Abstract: Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
    Type: Application
    Filed: June 26, 2015
    Publication date: December 31, 2015
    Inventors: Charles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John Hackett, Matthew Frankel, Kenn Forberg